(MENAFN- GlobeNewsWire - Nasdaq) Magneto-DNA Biosensors Market Set to Reach $2.66 Billion by 2030 as Precision Diagnostics AdvanceDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Magneto-Deoxyribonucleic Acid (DNA) Biosensors Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.
The global magneto-deoxyribonucleic acid (DNA) biosensors market is experiencing rapid growth as healthcare systems, research institutions and diagnostic laboratories increase their use of sensitive genetic detection technologies. The market is projected to grow from $1.46 billion in 2025 to $1.64 billion in 2026, representing a compound annual growth rate (CAGR) of 12.7%. This expansion reflects advances in nanotechnology, higher demand for cancer diagnostics, increased biomedical research investment and wider adoption of magnetic nanoparticles in biosensing applications.
Looking ahead, the magneto-DNA biosensors market is forecast to reach $2.66 billion by 2030, expanding at a CAGR of 12.9%. Growth during the forecast period will be supported by the increasing adoption of personalized medicine, greater demand for early disease detection, integration of artificial intelligence-based data analytics and expansion of decentralized diagnostic testing. Continued development of highly sensitive, portable biosensor devices is also expected to improve access to rapid genetic analysis across clinical and non-clinical settings.
Magneto-DNA biosensors combine magnetic materials with DNA-based recognition mechanisms to detect targeted genetic sequences with high sensitivity. Magnetic nanoparticles and magnetic fields enhance interactions between target DNA and sensing platforms, enabling accurate identification of mutations, pathogens and gene expression profiles. Key product categories include electrochemical and optical magneto-DNA biosensors, supported by hardware, assay kits, reagents, consumables, software and data analytics.
Technologies shaping the magneto-DNA biosensors market include giant magnetoresistance and tunnel magnetoresistance sensors, superparamagnetic nanoparticle-based sensors, Hall effect sensors and magneto-elastic biosensors. Major market trends include broader use of superparamagnetic nanoparticles, rising demand for point-of-care genetic diagnostics, greater integration of magnetoresistive technologies and growing deployment in multiplexed pathogen detection. Liquid biopsy applications are also creating opportunities in oncology by supporting minimally invasive biomarker analysis and disease monitoring.
The increasing global burden of infectious diseases remains a major market driver. Magneto-DNA biosensors enable rapid identification of pathogen-specific DNA sequences, supporting early diagnosis, disease surveillance and timely clinical intervention. International travel, urbanization, climate change and evolving antimicrobial resistance patterns continue to increase the risk of outbreaks and cross-border transmission. According to the World Health Organization, global demand for malaria vaccines is expected to reach 40 million to 60 million doses annually by 2026 and increase to between 80 million and 100 million doses per year by 2030, highlighting sustained investment in infectious disease prevention and diagnosis.
Rising detection of genetic disorders is also strengthening demand for magneto-DNA biosensor technologies. Advances in genetic testing and broader screening programs are enabling earlier and more precise identification of inherited conditions. Magneto-DNA biosensors support the detection of gene mutations and chromosomal abnormalities, helping clinicians improve risk assessment, diagnosis and treatment selection. In November 2024, NHS Wales reported screening for more than 380 rare childhood diseases, with cystic fibrosis occurring at a rate of 3.93 cases per 10,000 live births.
Personalized medicine represents another important growth opportunity. Magneto-DNA biosensors can identify clinically relevant mutations and biomarkers rapidly, supporting targeted therapies and more individualized treatment strategies. The Personalized Medicine Coalition reported that the US Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six approvals in 2022. This increase demonstrates the growing role of genomic information in therapeutic development and clinical decision-making.
Applications for magneto-DNA biosensors extend across infectious disease diagnostics, oncology and liquid biopsy, genetic testing and screening, food safety, environmental monitoring, pharmaceutical research and drug development. Primary end users include hospitals, diagnostic laboratories, academic and research institutions, pharmaceutical and biotechnology businesses, food testing laboratories, environmental agencies and contract research organizations.
North America was the largest region in the magneto-deoxyribonucleic acid biosensors market in 2025, supported by established diagnostic infrastructure, biomedical research activity and adoption of advanced genetic testing. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa, including Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Product: Electrochemical Magneto-Deoxyribonucleic Acid Biosensors; Optical Magneto-Deoxyribonucleic Acid Biosensors
2) By Component: Hardware or Devices; Assay Kits and Reagents; Consumables; Software and Data Analytics
3) By Technology: Magnetoresistive Sensors (GMR/TMR); Superparamagnetic Nanoparticle-Based Sensors; Hall Effect Sensors; Magneto-Elastic Biosensors
4) By Application: Infectious Disease Diagnostics; Oncology and Liquid Biopsy; Genetic Testing and Screening; Food Safety Testing; Environmental Monitoring; Research and Drug Development
5) By End User: Hospitals and Diagnostic Laboratories; Academic and Research Institutions; Pharmaceutical and Biotechnology Companies; Food and Beverage Testing Laboratories; Environmental Testing Agencies; Contract Research Organizations
Subsegments:
1) By Electrochemical Magneto-DNA Biosensors: Voltammetric Detection; Amperometric Detection; Impedimetric Detection; Potentiometric Detection
2) By Optical Magneto-DNA Biosensors: Fluorescence Detection; Surface Plasmon Resonance Detection; Colorimetric Detection; Chemiluminescence Detection
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment